CG Oncology (CGON) PT Raised to $79 by Morgan Stanley on Strong Clinical Pipeline for Bladder Cancer Treatment
CG Oncology Inc. (NASDAQ:CGON) is one of the best new stocks to buy right now.
Cg Oncology Inc. (CGON)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.00 | 1,515,151 | $49,999,983.00 | 1,515,151 | 2025-09-11 | Filing | |
| $19.00 | 400,000 | $7,600,000.00 | 4,958,810 | 2024-01-29 | Filing | |
| $19.00 | 1,315 | $24,985.00 | 1,315 | 2024-01-29 | Filing | |
| $19.00 | 2,000 | $38,000.00 | 2,000 | 2024-01-29 | Filing | |
| $19.00 | 263,157 | $4,999,983.00 | 613,928 | 2024-01-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.09 | 5,000 | $200,450.00 | 0 | 2025-09-30 | Filing | |
| $39.19 | 12,755 | $499,868.45 | 0 | 2025-09-29 | Filing | |
| $38.99 | 3,574 | $139,350.26 | 0 | 2025-09-19 | Filing | |
| $39.01 | 19,112 | $745,559.12 | 0 | 2025-09-18 | Filing | |
| $35.10 | 1,000 | $35,100.00 | 0 | 2025-09-15 | Filing |
News See All
14 Best New Stocks to Buy Right Now
On September 15, Tom Sosnoff, Tastylive founder, joined 'Squawk Box' on CNBC to discuss the state of the IPO market and what to make of the surge of IPO offerings.
CG Oncology's Bladder Cancer Drug Shows Strong Clinical Data, Drives Optimism Despite Price Target Cut
CG Oncology Inc. (NASDAQ:CGON) is one of the best IPO stocks to buy according to Wall Street analysts.
H.C. Wainwright Reiterates a Buy on CG Oncology (CGON), Keeps the PT
CG Oncology, Inc. (NASDAQ:CGON) is one of the Best Small-Cap Growth Stocks to Buy Right Now. On August 11, Andres Y. Maldonado from H.C. Wainwright reiterated a Buy rating on CG Oncology, Inc.
11 Best Small-Cap Growth Stocks to Buy Right Now
On August 14, Jonathan Krinsky of BTIG joined CNBC for an interview to discuss the sustainability of the recent small-cap rally.
13 Best IPO Stocks to Buy According to Wall Street Analysts
On August 14, Tony Kim, Centerview Partners co-president, joined CNBC's 'Closing Bell: Overtime' to discuss the IPO market and the dealmaking environment.
11 Best Future Stocks to Buy Now
Over the past year, investors have poured money into cutting-edge technologies like artificial intelligence and electric cars.
Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating
CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 17, Morgan Stanley raised the firm’s price target on CG Oncology, Inc.
13 Best Pharma Stocks to Buy According to Wall Street Analysts
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Hedge Fund Resource Center Billionaire Hedge Funds
